From an onsite 3D printing studio collaboration to artificial intelligence-based software designed to detect and diagnose wrist fractures to numerous total joint and spine technologies, HSS is leveraging its leadership and expertise to blaze a unique path of orthopedic innovation and commercialization. What enables the hospital’s success? HSS embraces a culture of creativity and innovation. Douglas Leach, Managing Director at HSS’ Innovation Institute and a former product development vice president at Stryker and OrthoSensor, shares a vision for the future of innovating within the world of musculoskeletal care. He’ll provide a glimpse of shifting commercialization dynamics and show how the entire industry must embrace a culture of innovation and collaboration—from caregivers to commercial partners to contract manufacturers—to propel orthopedics forward.
Douglas Leach, Managing Director, Device Innovation, HSS Innovation Institute
In his role at the Innovation Institute, Mr. Leach is focused on driving the discovery, assessment, development and commercialization functions related to musculoskeletal devices at HSS. Prior to HSS, Mr. Leach spent more than 25 years in the orthopedic device industry, working across R&D, product marketing and business management functions. He has experience in both large corporate settings and early-stage technology companies, having served as a former Vice President with Stryker, as well as Senior Vice President at OrthoSensor.